Stocks-AXSM-Axsome Therapeutics Inc

AXSM Axsome Therapeutics Inc

94.81 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Axsome Therapeutics Inc's revenues increased by ∞% and amounted to 50.04M. Net income decreased by 43.50% to -187.13M. Net assets increased by 183.12% to 109.56M and EPS decreased from -3.47 to -4.60.
AXSM's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
86.93%
Net Profit Margin
-93.50%
Operating Margin
-82.15%
Return On Investment
-97.85%